Invasive monitoring: should we place it in all HF patients?
Mazimba, Sula
( University of Virginia
, Charlottesville
, Virginia
, United States
)
De Boer, Rudolf
( Erasmus MC
, Rotterdam
, Netherlands
)
Brugts, Jan Jasper
( ERASMUS MC THORAXCENTER
, Rotterdam
, Netherlands
)
Author Disclosures:
Sula Mazimba:DO NOT have relevant financial relationships
| Rudolf De Boer:DO have relevant financial relationships
;
Research Funding (PI or named investigator):European Researc Council:Active (exists now)
; Advisor:Medtronic:Active (exists now)
; Speaker:Zoll:Past (completed)
; Speaker:NovoNordisk:Active (exists now)
; Speaker:AstraZeneca:Past (completed)
; Speaker:Abbott:Past (completed)
; Research Funding (PI or named investigator):Abbott:Active (exists now)
; Research Funding (PI or named investigator):NovoNordisk:Active (exists now)
; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now)
; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
; Research Funding (PI or named investigator):Alnylam:Active (exists now)
; Research Funding (PI or named investigator):Netherlands Heart Foundation:Active (exists now)
| Jan Jasper Brugts:DO have relevant financial relationships
;
Speaker:Astra Zeneca:Past (completed)
; Speaker:Vifor:Past (completed)
; Speaker:Novartis:Past (completed)
; Speaker:Boehringer:Past (completed)
; Speaker:Abbott:Past (completed)